Every year, approximately 400,000 children develop cancer, and their chance of survival depends on where they were born. To fight this inequity, St. Jude Children's Research Hospital, Pan American Health Organization, UNICEF, World Health Organization, and partners have united under the Global Platform for Access to Childhood Cancer Medicines to create a sustainable model for the delivery of childhood cancer medicines to low- and middle-income countries. UNICEF secures and delivers affordable, quality-assured medicines, a critical step in protecting children from counterfeit and sub-standard medicines and upholding every child’s right to health.
This is so awesome!! You are a great speaker and advocate of a very important issue. ♥️♥️
Go, Hedy! 👏
Great presentation Hedy! Such an inspiring and impactful initiative. 🌍 Grateful to see organizations like St. Jude, WHO, and UNICEF working together to close this gap for children everywhere. Would be wonderful to see Cambodia included on this list — every child deserves the same chance at life, no matter where they’re born. 💛
Congrats Hedy Ip 💪👏💙
Great job Hedy Ip
This initiative is not only timely but profoundly transformative. The stark reality that a child’s survival from cancer can hinge on geography is an injustice that global health actors cannot ignore. By uniting St. Jude Children’s Research Hospital, PAHO, UNICEF, WHO, and partners under the Global Platform for Access to Childhood Cancer Medicines, we see a paradigm shift from fragmented responses toward a systemic, equity-driven approach. UNICEF’s role in securing and delivering affordable, quality-assured medicines is pivotal. It addresses two urgent needs simultaneously: safeguarding children against the scourge of counterfeit and sub-standard drugs, and upholding the universal right to health enshrined in the Convention on the Rights of the Child. What makes this model powerful is its focus on sustainability—building resilient supply chains for low- and middle-income countries rather than short-term fixes. If scaled effectively, this platform can set a new standard in global health equity, proving that with coordinated leadership, scientific rigor, and compassion, geography need not determine a child’s chance at life. #GlobalHealth #ChildhoodCancer #EquityInCare #HealthForAll
great work
An extraordinary and much-needed initiative. The reality that a child’s chance of surviving cancer is determined not by the biology of the disease, but by the geography of their birth, is one of the starkest inequities in global health. The Global Platform for Access to Childhood Cancer Medicines—anchored by UNICEF, WHO, PAHO, and St. Jude Children’s Research Hospital—represents not only a practical solution but a moral imperative. By securing affordable, quality-assured medicines, UNICEF and partners are addressing a dual crisis: the scarcity of essential cancer drugs in low- and middle-income countries and the devastating risks posed by counterfeit or sub-standard alternatives. Beyond supply chains, this effort strengthens health systems, safeguards trust, and affirms every child’s fundamental right to life-saving treatment. This initiative is a testament to what global solidarity can achieve when innovation, science, and justice converge. A world where birthplace no longer determines survival must remain our shared horizon. #ChildHealth #GlobalEquity #CancerCare #RightToHealth #UNICEF #WHO #StJude #GlobalSolidarity
Fostering Accountability in Humanitarian and Development Programmes. Led and managed multi-sectoral programmes in Asia Pacific Countries and Turkiye.
1wCongrats Hedy Ip.